Closure beyond clozapine: successfully averting rebound symptoms in a patient with schizoaffective disorder and agranulocytosis

Summary‘Rebound’ or ‘withdrawal’ symptoms are frequently observed after a sudden discontinuation of clozapine. We describe a patient with treatment-resistant schizoaffective disorder who developed agranulocytosis on clozapine but was successfully switched to treatment with olanzapine with no deterio...

Full description

Bibliographic Details
Main Authors: Alastair Green, Thomas Stephenson, Eromona Whiskey, Sukhi S. Shergill
Format: Article
Language:English
Published: Cambridge University Press 2019-05-01
Series:BJPsych Open
Subjects:
Online Access:https://www.cambridge.org/core/product/identifier/S2056472419000310/type/journal_article